کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5848748 | 1561704 | 2015 | 7 صفحه PDF | دانلود رایگان |
- Obesity is characterized by low levels of chronic inflammation.
- Chronic inflammation is thought to reduce efficacy of vaccines for infectious diseases.
- Chronic inflammation may aggravate the symptoms of influenza virus infection.
- These effects seem to occur because of dysfunction of macrophages.
- Dysfunction of macrophages may influence vaccine efficacy and virus pathogenicity.
Obese individuals show increased susceptibility to infection, low vaccine efficacy, and worse pathophysiology. However, it is unclear how obesity affects these events. The aim of this study was to investigate the effect of obesity-triggered chronic inflammation on immune cells after influenza virus infection. Control and lipopolysaccharide mice, in which an osmotic pump continually released Tween saline or lipopolysaccharide, were prepared and 3 weeks later were infected with pandemic H1N1 2009 influenza A virus. In lipopolysaccharide mice, we found a reduction in macrophage activation markers in the steady state, and reduced production of pro-inflammatory cytokines including tumor necrosis factor-α, interleukin-1β, and interleukin-6, in restimulated peritoneal macrophages. Interestingly, lipopolysaccharide-triggered chronic inflammation exacerbated the severity of pathological symptoms in the lungs after challenge with influenza virus. Taken together, the increased severity of virus-induced symptoms in obese individuals with chronic inflammation may be, at least partially, caused by macrophage dysfunction.
Journal: Environmental Toxicology and Pharmacology - Volume 40, Issue 3, November 2015, Pages 924-930